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Abstract: A phytochemical study of the root and bark ofBrucea antidysenterica J. F. Mill. (Simaroubaceae)
afforded three new compounds, including a stilbene glycoside bruceanoside A (1), and two
canthinone alkaloids bruceacanthinones A (3) and B (4), along with ten known secondary metabolites,
rhaponticin (2), 1,11-dimethoxycanthin-6-one (5), canthin-6-one (6), 1-methoxycanthin-6-one (7),
2-methoxycanthin-6-one (8), 2-hydroxy-1,11-dimethoxycanthin-6-one (9), β-carboline-1-propionic acid
(10), cleomiscosin C (11), cleomiscosin A (12), and hydnocarpin (13). The structures of all the compounds
were determined using spectrometric and spectroscopic methods including 1D and 2D NMR, and
HRSEIMS. The identities of the known compounds were further confirmed by comparison of their data
with those reported in the literature. The root and bark methanolic extracts, the dichloromethane and
ethyl acetate soluble fractions, and the isolated compounds (3–13), were assessed for their cytotoxicity
against the cancer cell lines A-549, MCF-7, and PC-3. The results suggested that compounds in the
extracts might possess a synergic action in their cytotoxicity.
Keywords: Brucea antidysenterica; Simaroubaceae; bruceanoside A; bruceacanthinones A–B; cytotoxicity
1. Introduction
Plants from theBrucea genus (Simaroubaceae) have been extensively investigated for their chemical
constituents and pharmacological properties since 1900 [1]. Among the numerous metabolites reported
so far, quassinoids, also called nigakilactones and canthinone alkaloids, are the most important class
of compounds [1], with demonstrable biological activities, including anti-amoebic [2], antitumour [3–5],
antiplasmodial [6,7], and antituberculosis [8] effects. As the name indicates, Brucea antidysenterica
J. F. Mill. is used in traditional medicine for the treatment of dysentery and also against malaria,
diarrhoea, and stomach aches [9,10]. In Ethiopia, the plant is also used for the treatment of tumors,
and a follow-up investigation revealed that the compound has promising activity in vitro against
several lymphoma, leukemia, and myeloma cell lines [11]. In addition, the 80% methanolic extract from
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the leaf was assayed for antioxidant activity, showing significant inhibition of 87.57% for the water
soluble fraction as measured by DPPH assay, and 72.57 mg AAE/g as measured by FRAP assay [12].
Moreover, 50 mg/mL of the aqueous leaf extract gave a better wound healing effect than the control
group when applied topically on a mouse model [13]. The aqueous, methanolic, and chloroform crude
extracts of the seeds delivered significant Plasmodium berghei suppression in 6–8 week old Swiss albino
mice of both sexes when given at 600 mg/kg body weight, while the acute toxicity test at a single dose
of 2000 mg/kg body weight led to the death of all mice within 24 h for each of above extracts [14].
It should be noted that the first pure compound reported from the plant, the triterpene quassinoid
bruceantin, was already isolated in 1973 from the alcoholic stem bark extract and shown in the
follow-up to possess activities related to cell apoptosis and proliferation, angiogenesis, inflammation,
and metabolic diseases [11,15,16]. Recently, we identified bruceadysentoside A, a pregnane glycoside,
from the leaves of B. antidysenterica, in addition to seventeen other compounds, including hydnocarpin,
which exhibited the strongest antiproliferative activity with IC50 values of ≈100 µM and ≈200 µM
against PC-3 and HT-29, respectively [17]. In continuation of our program to explore the phytochemicals
of B. antidysenterica and their cytotoxicity, we investigated the bark and root of this plant. In this report,
we describe the isolation and structural elucidation of one new stilbene (1) and two new canthinone
alkaloids (3 and 4) and their cytotoxic activities.
2. Results
The bark and root of B. antidysenterica were separately extracted with MeOH. A small amount
of each extract was stored for their in vitro-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) cytotoxicity/viability assay on A-549, MCF-7, and PC-3 cell lines. Based on their similar
Thin-Layer Chromatography (TLC) profiles both bark and root extracts were combined and partitioned
with dichloromethane and ethyl acetate to afford two major fractions. Subsequent purification of these
fractions led to the isolation of three new compounds, including one new stilbene glycoside (1) and two new
canthinone alkaloids (3 and 4). The comparison of our data with those reported in the literature allowed
identification of the known compounds, such as rhaponticin (2) [18], 1,11-dimethoxycanthin-6-one
(5) [19], canthin-6-one (6) [19], 1-methoxycanthin-6-one (7) [20], 2-methoxycanthin-6-one (8) [21],
2-hydroxy-1,11-diméthoxycanthin-6-one (9) [22], β-carboline-1- propionic acid (10) [23], cleomiscosin
C (11) [24], cleomiscosin A (12) [25], and hydnocarpin (13) [26] (Figure 1).
Compound 1 was obtained as a white amorphous powder. Its molecular formula C29H39O11 was
deduced from the ESIMS (Figures S1 and S2) and from the (+)-HR-ESIMS showing the pseudo-molecular
ion peak at m/z 563.2488 [M + H]+ (calculated for C29H39O11, 563.2492). The 1H NMR spectrum (Table 1,
Figure S3) showed characteristic signals of two aromatic methoxyl (δ 3.80, 6H), two trans-olefinic
protons (δ 6.99 and 7.20, d, J = 16.4 Hz, 1H each), and the occurrence of two independent aromatic
rings, each carrying three protons organized in two different spin systems: The first ring (A) showed
the AMX-type signals (δ 6.78 and 6.82, brs, 1H each; 6.52, t, J = 2.2 Hz, 1H) and were attributed to the
protons of a 1,3,5-trisubstituted aromatic ring, while the second ring (B) exhibited 1H signals of an
A2B2-coupled spin system (δ 6.95 and 7.58, d, J = 8.8 Hz, 2H each) which were assignable to the protons
of a 1,4-disubstituted aromatic ring. Furthermore, the presence of two anomeric proton signals was
depicted at δ 4.89 (1H, d, J = 7.6 Hz) and 4.56 (1H, d, J = 1.7 Hz), and a methyl doublet of rhamnose
was at δ 1.11 (3H, d, J = 6.1 Hz). These three 1H signals coupled to the HSQC and DEPT experiments
allowed us to assign their 13C resonances at δ 101.0, 101.0, and 18.3, respectively (Figures S4–S6).
All these findings indicated that compound 1 was a stilbene glycoside with two sugar moieties; one
of them might be rhamnose [27]. Careful analysis of the HMBC spectrum (Figure 2 and Figure S7)
of compound 1 showed cross-peak correlations between the proton signal at δ 6.99 (H-α) and the carbon
signals of the ring A appearing at δ 129.9 (C-1), 107.6 (C-6), and 105 (C-2), while the proton signal at
δ 7.20 (H-β) showed correlations with the carbon signals involved in the ring B and appearing at δ
139.7 (C-1′) and 128.4 (C-2′/C-6′), confirming that rings A and B are linked through the trans-orientated
bond Cα–Cβ characteristic of stilbene. Furthermore, the two methoxy groups were connected at C-3
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and C-5 in ring A according to the correlations observed between the proton signals at δ (3.80, s, 6H)
and the carbon signals at δ 159.3 (C-3) and 160.2 (C-5). Therefore, the aglycone was characterized
to be pterostilbene, and the two remaining sugar moieties might be connected at the only position
C-4′ (δC159.8) in cycle B suggesting that 1 is a pterostilbene glycoside [28]. This partial conclusion was
further supported by the mass spectra in positive and negative ionization mode (Figures S1 and S2).
Briefly, the (–)-HR-ESIMS showed a peak at 255.106 corresponding to the fragment [M − rha − glc]−;
while the (+)-HR-ESIMS exhibited signal at 441.156 attributed to the fragment [M + Na − rha]+. Both
observations indicated that the two sugar units are linked to each other and connected to the aglycone
pterostilbene via the glucose subunit. Further proof was obtained from the long-range correlation
between the anomeric proton of glc at δ 4.89 (d, J = 7.6 Hz, glc H-1) and the carbon signal at δ 159.8
(C-4′). The linkage of the two sugar moieties was established from the HMBC correlations between δ
4.56 (1H, d, J = 1.6 Hz, ara H-1) and δ 66.8 (glc C-6) (Figure 2). The anomeric proton of the glucose was
assigned with β-configuration based on its 3JH-1,H-2 coupling constant of 7.6 Hz (Table 1), while the
anomeric proton of rhamnose was assigned with α-configuration due to the characteristic 13C chemical
shift of C-5 (rha) at δ 68.8 (Table 1) [29]. Based on all these above evidence, the structure of compound
1 was assigned to be pterostilbene 3-O-α-rhamnopyranosyl(1→6)-β-glucopyranoside and given the
trivial name, bruceanoside A.
Table 1. 1H (600 MHz) and 13C (150 MHz) NMR assignments of 1 in DMSO-d6.
No
1
δC δH (mult., J in Hz)
α 126.4 6.99 (1H, d, 16.4)
β 129.1 7.20 (1H, d, 16.4)
1 129.9 –
2 105.6 6.82 (1H, brs)
3 159.3 –
4 101.9 6.52 (1H, t, 2.2)
5 160.2 –
6 107.6 6.78 (1H, brs)
1′ 139.7 –
2′/6′ 128.4 7.58 (2H, d, 8.8)
3′/5′ 114.6 6.95 (2H, d, 8.8)
4′ 159.8 –
OCH3-3/5 55.6 3.80 (6H, s)
sugar moieties
glc-1 101.0 4.89 (1H, d, 7.6)
2 73.7 3.19 (1H, m)
3 75.8 3.52 (1H. m)
4 70.8 3.65 (1H, m)
5 76.9 3.30 (1H, m)
6 66.8 3.41 (1H, m)3.87 (1H, m)
rha-1 101.0 4.56 (1H, d, 1.6)
2 71.2 3.42 (1H, m)
3 70.3 3.46 (1H, m)
4 72.5 3.18 (1H, m)
5 68.8 3.43 (1H, m)
6 18.3 1.11 (3H, d, 6.1)
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Compound 3, named bruceacanthinone A, was obtained as an amorphous yellow solid.
Its molecular formula was assigned as C15H10N2O3 with help of the ESIMS (Figure S10) and the
(+)-HR-ESIMS (m/z 289.0570 [M + Na]+, calculated for C15H10N2O3Na, 289.0589) counting for
12 double-bond equivalents. The Dragendorff’s test was positive, suggesting that 3 was an alkaloid.
On its 1H NMR spectrum (Table 2, Figure S11), the signals of two cis-coupled protons [δ 8.08 and 6.90
(d, J = 9.7 Hz, 1H each)] were observed, which are characteristic of the lactam ring of canthin-6-one [30].
Furthermore, there were signals corresponding to one methoxyl at δ 4.29 (3H, s), one hydroxyl at δ 8.52
(1H, s), and signals of a four-spin ABMX-type system supported by the COSY correlations (Figure 3)
observed between the four proton signals at δ 8.70 (1H, dd, J = 1.2 and 7.8 Hz), 8.26 (1H, dd, J = 1.0
and 7.6 Hz), 7.70 (1H, td, J = 1.0, 7.6, and 7.8 Hz), and 7.58 (1H, td, J = 1.2, 7.6, and 7.8 Hz). The 13C
NMR spectrum for 3 (Table 2, Figure S12)) confirmed 16 carbon signals which were clearly sorted by
and HSQC (Figure S13) experiments into one methoxyl (δ 57.2), one ketone carbonyl characteristic
of conjugated lactam (δ 159.6), six methines, and seven quaternary carbons. All these data were similar
to those of hub n , canthin-6-one alkaloid recently reported from the stem bark of Picrolemma
huberi [31]. The comparison of their NMR data suggested that, besides some changes in chemical
shifts, which could be explained by the solvent effect during the analysis, the main and more relevant
change is the presence of 1H and 13C signals of two methoxyl groups in huberine rather than one
in compound 3. This partial conclusion could be further confirmed by the difference of 14 mass units
between the two compounds. The HMBC spectrum of 3 (Figure 3 and Figure S14) showed the same
cross-peaks observed in huberine, indicating that the two compounds share the same core structure [31].
Furthermore, the HMBC experiment allowed the assignment of the methoxyl unit in C-2 and the
hydroxyl group in C-1 according to the cross-peaks observed between δ 4.29 (OCH3) and δ 159.6 (C-2),
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and between δ 8.52 (OH) and δ 159.6 (C-2), 140.0 (C-1), and 119.2 (C-14). On the basis of all the evidence
obtained, the structure of 3 was deduced as 1-hydroxy-2-methoxycanthin-6-one.
Table 2. 1H (600 MHz) and 13C (150 MHz) NMR assignments of 3 and 4 in DMSO-d6.
No
3 4
δC δH (mult., J in Hz) δC δH (mult., J in Hz)
1 140.0 – 140.4 –
2 152.6 – 151.5 –
4 139.0 8.08 (1H, d, 9.7) 139.9 8.04 (1H, d, 9.8)
5 127.3 6.90 (1H, d, 9.7) 125.9 6.90 (1H, d, 9.8)
6 159.6 – 160.0 –
8 117.1 8.70 (1H, dd, 1.2, 7.8) 112.9 8.40 (1H, dd, 0.8, 8.2)
9 130.7 7.70 (1H, td, 1.0, 7.6, 7.8) 132.3 7.65 (1H, t, 8.2)
10 127.5 7.58 (1H, td, 1.2, 7.6, 7.8) 108.0 7.01 (1H, dd, 0.8, 8.2)
11 125.0 8.26 (1H, dd, 1.0, 7.6) 156.1 –
12 123.1 – 126.8 –
13 136.4 – 139.9 –
14 130.7 – 132.9 –
15 128.7 – 132.3 –
16 126.1 – 126.8 –
OMe-2 57.2 4.29 (3H, s) 56.3 4.09 (3H, s)
OMe-11 – – 57.8 4.28 (3H, s)
OH-1 – 8.52 (1H, s) – 8.50 (1H, s)
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Compound 4 was isolated as an amorphous yellow solid and its molecular formula was deduced
from its ESIMS (Figure S16) and HR-ESIMS as C16H12N2O4 (m/z 297.0855, calculated for C16H13N2O4,
298.0875), exhibit ng 30 amu mo than that of 3. We found that compounds 3 and 4 are structurally
related according to their close 1H and 13C NMR data (Table 2, Figures S17 and S18). The two main
differences were the presence of an additional methoxyl group in compound 3 (δ 4.28, 57.8) and the
occurrence of a three-spin ABC-system rather of the four-spin ABMX-system previously observed
in 3. All these findings suggested that compound 4 is a derivative of 3 in which a methoxyl group
is attached as substituent on the ring A. Therefore, the placement of this additional methoxyl group
was easily done with the HMBC experiment (Figure 3 and Figure S19) which exhibited a cross-peak
of correlation between δ 4.28 (3H, s) and δ 160.0 (C-11). The structure of bruceacanthinone B (4) was
finally determined as 2,11-dimethoxy-1-hydroxycanthin-6-one.
The root and bark crude extracts, their dichloromethane and ethyl acetate soluble main fractions,
and the compounds 3–13, were assessed for their cytotoxic potency by MTT assay against three human
cancer cell lines A-549, MCF-7, and PC-3 using etoposide as the positive control (3.5 ± 0.5, 10.2 ± 1.2,
and 7.9 ± 1.1 µg/mL, respectively for A-549, MCF-7, and PC-3 see Table 3). The crude extracts and the
fractions displayed cytotoxicity with IC50 values ranging from 50.0 ± 5.2 to 80.5 ± 1.8 µg/mL. However,
the potencies of isolated compounds 3–13 were indicated by IC50 values more than the double of those
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of crude extracts (Table 3). This observation supported that the isolated compounds were less cytotoxic
in single assay compared to the crude extracts and fractions. The results suggested that compounds
from B. antidysenterica root and bark extracts might have a synergic effect in cytotoxicity assay.
Table 3. Cytotoxicity of extracts, fractions, and isolated compounds from Brucea antidysenterica.
Samples
IC50 in µg/mL
A-549 MCF-7 PC-3
Root extract 75.2 ± 3.2 80.5 ± 1.8 77.7 ± 2.5
Bark extract 65.1 ± 1.5 72.3 ± 3.5 70.2 ± 4.2
DCM 50.0 ± 5.2 55.1 ± 4.2 57.0 ± 5.3
EA 61.5 ± 3.2 58.1 ± 1.9 55.8 ± 2.4
3 >250 >250 195.5 ± 9.5
4 150.3 ± 8.5 157.5 ± 7.5 160.5 ± 5.5
5 >250 >250 >250
6 175.6 ± 6.1 170.3 ± 5.8 177.3 ± 5.9
7 125.8 ± 7.2 152.1 ± 11.2 155.1 ± 5.3
8 121.5 ± 8.2 126.2 ± 5.5 130.9 ± 7.4
9 138.1 ± 9.7 145.2 ± 9.9 151.5 ± 8.3
10 >250 >250 >250
11 >250 >250 >250
12 130.8 ± 7.4 132.1 ± 11.2 130.1 ± 5.3
13 >250 >250 >250
Etoposide 3.5 ± 0.5 10.2 ± 1.2 7.9 ± 1.1
3. Materials and Methods
3.1. General Experimental Procedures
Chromatographic solvents were purchased from Fisher Scientific, UK, and used without further
purification. Optical rotations were measured in methanol on a JASCO DIP-360 digital polarimeter
using a 10 cm cell. Ultraviolet spectra were recorded on a Hitachi UV 3200 spectrophotometer
in MeOH. Infrared spectra were recorded on a JASCO 302-A spectrophotometer. ESIMS was recorded
on a Finnigan LCQ with a Rheos 4000 quaternary pump (Flux Instrument). EIMS were recorded on
a Varian MAT 311A spectrometer (70 eV). EIMS was performed on a JEOL HX 110 mass spectrometer.
The 1H and 13C NMR spectra were recorded at 600 and 150 MHz, respectively, on a Bruker AMX 600
NMR spectrometer. Chemical shifts are reported in δ (ppm). Column chromatography was carried out
on silica gel (70–230 mesh, Merck) and flash silica gel (230–400 mesh, Merck). TLC was performed on
Merck precoated silica gel 60 F254 aluminum foil, using ceric sulfate spray reagent for visualization.
The purity of compounds was investigated by HPLC. The degree of purity of the positive control
compound was ≥98%, while that of the isolated compounds was ≥95%. All reagents used were
analytical grade.
3.2. Plant Material
The bark and root of B. antidysenterica J. F. Mill. were collected in June 2013 at Bakouok (Bamenda)
in the Northwest Region of Cameroon and were authenticated by Nana Victor, a botanist at the National
Herbarium of Cameroon where a voucher specimen was deposited under the registration number
54,605 HNC.
3.3. Extraction and Isolation
The air-dried and powdered bark (2.5 kg) and root (1.2 kg) of B. antidysenterica were separately
extracted twice at room temperature with MeOH for 48 h and 24 h, respectively. The solvent was
removed by evaporation under reduced pressure to obtain the crude extracts from bark (85.6 g) and
root (38.7 g). A small amount (≈5 g) of each extract was kept for cytotoxicity assay against three human
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cancer cell lines A-549, MCF-7, and PC-3. The two crude extracts were combined according to their
very similar compositions observed on a TLC plate. The mixed crude extract (114.3 g) was dissolved
in water and partitioned with n-hexane, dichloromethane (DCM), and ethyl acetate (EtOAc) to afford
three main fractions A (12.2 g), B (23.6 g), and C (41.7 g), respectively. Fraction A was mainly oils and
fats; the remaining water-soluble fraction was dried and kept for further analysis while the fractions B
and C were purified to yield the thirteen compounds identified in this report. More closely, the DCM
soluble fraction B was subjected to silica gel column chromatography using a gradient of EtOAc
in n-hexane to obtain a total of 73 fractions which were combined based on their TLC profiles into four
main subfractions B1–B4. Repeated silica gel column chromatography of the subfractions B1 (7.3 g)
and B2 (5.8 g) separately eluted with a gradient of DCM in n-hexane yielded compounds 6 (10.5 mg)
and 7 (15.5 mg) from B1, while compound 8 (8.7 mg) was obtained from B2. Similarly, the subfractions
B3 (6.2 g) was further purified on silica gel column chromatography with DCM-EtOAc gradient to give
compounds 3 (9.3 mg), 4 (6.4 mg), and 5 (4.2 mg). Additionally, the EtOAc soluble fraction C was
chromatographed on silica gel with a DCM-EtOAc gradient followed by a gradient of MeOH in EtOAc.
As a result, 72 fractions of ca. 100 mL each were collected and combined into the subfractions C1–C3 on
the basis of TLC. Purification of C1 (10.8 g) over a silica gel column chromatography with the isocratic
system DCM-EtOAc (1:2) gave compounds 9 (12.0 mg), 10 (14.0 mg), and 12 (11.8 mg). In the same
way, the subfractions C2 (12.4 g) and C3 (14.3 g) were separately chromatographed on silica gel eluted
with the isocratic system of 25% DCM in EtOAc to yield compounds 11 (12.3 mg) and 13 (8.7 mg) from
C2, and compounds 1 (9.6 mg) and 2 (5.6 mg) from C2.
3.3.1. Bruceanoside A (1)
White amorphous powder; mp −80.2◦ (ca. 0.4 acetone); Rf = 0.25 (CHCl3/MeOH, 4/1); IR (KBr)
νmax 3348, 2940, 2892, 1615, 1593, 1350, 1265, 1255, 890, 750 cm−1; UV (MeOH) λmax (log ε): 290 (4.25),
265 (4.15) nm; 1H NMR (600 MHz, DMSO-d6) and 13C NMR (150 MHz, DMSO-d6) data, see Table 1;
HRESIMS m/z 563.2488 [M + H]+ (calculated for C29H39O12, 563.2492).
3.3.2. Bruceacanthinone A (3)
Yellowish powder; Rf = 0.45 (CHCl3/MeOH, 9.5/0.5); IR (KBr) νmax 3375, 2950, 2350, 1690, 1600,
1435, 1142, 865, 765, 720 cm−1; UV (MeOH) λmax (log ε): 398 (3.95), 380 (3.90), 365 (3.60), 329 (4.10),
250 (4.70); 1H NMR (600 MHz, DMSO-d6) and 13C NMR (150 MHz, DMSO-d6) data, see Table 1;
HRESIMS m/z 289.0589 [M + Na]+ (calculated for C15H10N2O3Na, 289.0570).
3.3.3. Bruceacanthinone B (4)
Yellowish powder; Rf = 0.40 (CHCl3/MeOH, 9.5/0.5); IR (KBr) νmax 3370, 2945, 2350, 1700, 1650,
1440, 1143, 870, 766, 722 cm−1; UV (MeOH) λmax (log ε): 395 (3.90), 376 (3.92), 367 (3.61), 329 (4.15),
255 (4.65); 1H NMR (600 MHz, DMSO-d6) and 13C NMR (150 MHz, DMSO-d6) data, see Table 1;
HRESIMS m/z 297.0855 [M + H]+ (calculated for C16H13N2O4, 298.0875).
3.4. Cell Lines, Cell Cultures, and the MTT Assay
The potential cytotoxicity of Brucea antidysenterica bark and root extracts, their VLC fractions,
and some isolated compounds (3–10) were studied against cancer cell lines A-549 (human lung
adenocarcinoma), MCF-7 (human breast adenocarcinoma), and PC-3 (human prostate adenocarcinoma)
using the MTT assay [32,33]. Methods used for toxicity assays have been reported by us previously
in detail [34] and are presented here again. All cell lines were cultured in RPMI-1640 medium
supplemented with 10% fetal bovine serum and 1% antibiotic-antimycotic solution (100×). The cells
were cultured at 37 ◦C in 95% humidity and 5% CO2. For the MTT assays, the cells were washed using
phosphate-buffered saline and harvested by trypsinization. Cells were then seeded into 24 well plates
at a density of 1.2 × 104 cells/well in a working volume of 1 mL/well and allowed to grow for 24 h
before the commencement of each experiment. The cells were then treated for 24 h with different
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concentrations of test samples (crude extracts and fractions at 0, 0.8, 4, 20, 100, and 500 µg/mL and the
compounds at 0, 0.4, 2, 10, 50, 75, and 100 µg/mL). Dilutions of stock solutions were made in culture
media, yielding final sample concentrations and a final dimethyl sulfoxide (DMSO) concentration
of 0.1%, including the control. Each sample concentration was used to treat four wells of cells in each
24 well plate. After the 24 h treatment period, the toxicity of the samples on each cell line was quantified.
To achieve this, the medium in each well was replaced by MTT solution (500 µg/mL in medium)
and incubated for 2 h. Viability of cells was assessed by their ability to reduce the yellow dye MTT
to a blue formazan product [35]. The MTT reagent was removed, the formazan crystals were dissolved
in isopropanol, and the absorbance at 560 nm determined using a microplate reader (CLARIO Star
Microplate Reader, BMG Labtech, UK). The average absorbance value obtained from zero treatment
control (0.1% DMSO) wells was arbitrarily set at 100% for each plate, and the absorbance value for the
average of wells of cells treated with each test sample concentration was expressed as a percentage
of this control. Each assay was performed on a minimum of three separate occasions, and the IC50
values for each sample on each cell line were calculated using Microsoft Excel version 2013. The
anti-lung cancer semisynthetic glycoside drug etoposide was used as a positive control.
3.5. Statistical Analysis
All experiments were carried out in triplicate on separate occasions. Data were expressed as
means ± standard errors of the means. The graphs were plotted using nonlinear regression with the
use of Microsoft Excel version 2013.
4. Conclusions
The chemical investigation of the root and bark of Brucea antidysenterica afforded three new
compounds, including one stilbene glycoside bruceanoside A (1), and two canthinone alkaloids
bruceacanthinones, A (3) and B (4), along with ten known secondary metabolites sorted into six
canthinone alkaloid derivatives (5–10), two coumarin derivatives (11 and 12), one stilbene (2), and one
flavonoid (13). As expected from the genus Brucea, canthinone alkaloids were the most abundant
class of metabolites isolated during this study and might be classified as chemo markers of Brucea
genus. Furthermore, the cytotoxicity of the root and bark methanolic extracts, the dichloromethane
and ethyl acetate soluble fractions, and the isolated compounds (3–13), were assessed against the
cancer cell lines A-549, MCF-7, and PC-3. The results displayed decreasing of IC50 values from
crude extracts to the isolated compounds, and might suggest a synergistic action of compounds
in their cytotoxicity. Since the plant is used in traditional medicine, its extract might be considered an
important reservoir of cytotoxic compounds for the treatment of tumors. However, additional in vivo
toxicity evaluation of extracts, antiplasmodial or antibacterial activities of extracts and compounds,
and chemical investigation of other parts of the plants—leaves and fruits for instance—in addition
to supporting the use of this plant in folk medicine, will help to obtain further information to enrich
the pharmacology and chemistry of the genus Brucea.
Supplementary Materials: The spectra of compounds (1, 3, and 4) are available online.
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